Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1.
about
Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell ResponsesReprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection.Phenotypic and functional activation of hyporesponsive KIRnegNKG2Aneg human NK-cell precursors requires IL12p70 provided by Poly(I:C)-matured monocyte-derived dendritic cells.Dendritic-cell-based therapeutic cancer vaccinesExploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes.TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of ImmunotherapyNew insights into the phenotype of human dendritic cell populations.Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy.Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade.A review of dendritic cell therapy for cancer: progress and challenges.Human dendritic cells subsets as targets and vectors for therapy.Human dendritic cell subsets in vaccination.Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy.Dendritic cell vaccine against leukemia: advances and perspectives.Dendritic cell-targeted vaccines.Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and toleranceSoluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8+ T cells for adoptive immunotherapy of cancer and infections.Dendritic Cell Therapies for Hematologic Malignancies.Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccinesHuman CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-β.Langerhans cells and NK cells cooperate in the inhibition of chemical skin carcinogenesis.Comparative genomics analysis of mononuclear phagocyte subsets confirms homology between lymphoid tissue-resident and dermal XCR1(+) DCs in mouse and human and distinguishes them from Langerhans cellsCell-to-cell variability analysis dissects the plasticity of signaling of common γ chain cytokines in T cells.Timing Is Everything: Combining Post-Transplantation Adoptive Cell Therapy and Tumor Vaccines.Human dendritic cell subsets: an update.Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial.
P2860
Q26777948-8901CFBD-CEA4-4AC6-9E95-4514483E4A32Q33581986-9C647438-A44C-46B4-A5B7-1F9176226A83Q34289351-B4EC0AF1-E408-49AA-A12B-8CDCD5B1470EQ34360094-62570AE3-D97E-4DA8-8A46-A2D6CABD0E07Q35138155-6BA49393-E8E3-4F40-94D6-36B3B559A162Q35861964-26AC70FD-E5B7-471F-850A-D60B185AB30BQ36436758-9A2AED2A-532F-4BB2-AE3C-EED92D23F61DQ36526496-56099D10-D6AB-4318-9761-12FC42793985Q37008819-CA3C0F03-D090-48D3-ABC6-25D5C2BDA760Q37679267-FD6072EA-B0A6-4626-8814-1E6A1B576766Q38099612-CC143001-4312-46E0-ACB2-D39C532DC565Q38104772-77B99A5A-EBC6-4316-9773-221A28C42B86Q38110971-B7D01116-A874-4A23-A8E6-6A114E567D84Q38115438-E67549D2-3ADE-4A46-90C1-EBB43C2535A6Q38210813-84DF0766-396E-4795-A5AA-5FD3DD34C98BQ38218671-ACBEA56A-D7B5-4714-8D82-BB4B892F2CEAQ38719738-29909D6E-342F-4D1E-B7FD-0E32F323B372Q38768298-4B4449D3-642A-45A9-9CD0-C63CFE0C1D6AQ39289930-BF931CD2-76E6-48B0-9282-FB6F84166EF0Q39448911-38226DF4-7D9C-4B39-AB17-30489D2BA6E1Q40223687-C9251D31-30C8-4616-BF86-41A9B54BF26CQ40277855-0EEC2200-0100-405A-9298-908634CE42A6Q41112925-9FB23060-EAC8-42B9-A22F-F0D129212649Q41880484-C02D2CF4-732E-40EF-A6D7-AE8E803A9B2EQ47147990-638997FB-86E6-4A9B-9ABA-FCCB90404939Q50125373-437450B4-BEFF-4A6E-A5A4-10EEA6955B1AQ52731759-122CA80E-FF35-4FFE-973D-E04A6AC6653F
P2860
Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Human Langerhans cells use an ...... erentiation tumor antigen WT1.
@ast
Human Langerhans cells use an ...... erentiation tumor antigen WT1.
@en
type
label
Human Langerhans cells use an ...... erentiation tumor antigen WT1.
@ast
Human Langerhans cells use an ...... erentiation tumor antigen WT1.
@en
prefLabel
Human Langerhans cells use an ...... erentiation tumor antigen WT1.
@ast
Human Langerhans cells use an ...... erentiation tumor antigen WT1.
@en
P2093
P2860
P1433
P1476
Human Langerhans cells use an ...... ferentiation tumor antigen WT1
@en
P2093
Babak Mehrara
Brian C Betts
Christian Münz
David J Chung
Emanuela Romano
Erin T St Angelo
Francesca Avogadri
Glenn Heller
James W Young
Jesse W Cotari
P2860
P304
P356
10.1182/BLOOD-2011-09-382200
P407
P577
2012-04-17T00:00:00Z